Ghent University Academic Bibliography

Advanced

Drug formulations intended for the global market should be tested for stability under tropical climatic conditions

PG RISHA, Chris Vervaet UGent, G VERGOTE, Lucas Van Bortel UGent and Jean Paul Remon UGent (2003) EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 59(2). p.135-141
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Eur. J. Clin. Pharmacol.
volume
59
issue
2
pages
135-141 pages
Web of Science type
Article
Web of Science id
000184157900009
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
1.972 (2003)
JCR rank
74/183 (2003)
JCR quartile
2 (2003)
ISSN
0031-6970
language
English
UGent publication?
yes
classification
A1
id
211112
handle
http://hdl.handle.net/1854/LU-211112
date created
2004-04-09 09:18:00
date last changed
2008-02-22 22:49:58
@article{211112,
  author       = {RISHA, PG and Vervaet, Chris and VERGOTE, G and Van Bortel, Lucas and Remon, Jean Paul},
  issn         = {0031-6970},
  journal      = {EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
  language     = {eng},
  number       = {2},
  pages        = {135--141},
  title        = {Drug formulations intended for the global market should be tested for stability under tropical climatic conditions},
  volume       = {59},
  year         = {2003},
}

Chicago
RISHA, PG, Chris Vervaet, G VERGOTE, Lucas Van Bortel, and Jean Paul Remon. 2003. “Drug Formulations Intended for the Global Market Should Be Tested for Stability Under Tropical Climatic Conditions.” European Journal of Clinical Pharmacology 59 (2): 135–141.
APA
RISHA, P., Vervaet, C., VERGOTE, G., Van Bortel, L., & Remon, J. P. (2003). Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 59(2), 135–141.
Vancouver
1.
RISHA P, Vervaet C, VERGOTE G, Van Bortel L, Remon JP. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(2):135–41.
MLA
RISHA, PG, Chris Vervaet, G VERGOTE, et al. “Drug Formulations Intended for the Global Market Should Be Tested for Stability Under Tropical Climatic Conditions.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 59.2 (2003): 135–141. Print.